Table 2.
Logistic regression models of BZRA use at follow-up timepoints (1 where 1 is a BZRA within 90 days of the 6-month timepoint or 0 is no BZRA within 90 days)
| Model 1 (6-month) | Model 2 (12-month) | Model 3 (6-month) | Model 4 (12-month) | |
|---|---|---|---|---|
| n=2,009 | n=2,009 | n=2,009 | n=2,009 | |
| Active brochure only | 0.92 [0.76, 1.12] | 0.94 [0.78, 1.14] | 0.90 [0.72, 1.13] | 0.93 [0.76, 1.13] |
| Active brochure + telephone reinforcement | 0.96 [0.64, 1.44] | 1.16 [0.79, 1.71] | 0.89 [0.56, 1.42] | 1.16 [0.77, 1.75] |
| Ref: Control brochure | 1.00 | 1.00 | 1.00 | 1.00 |
| Montana | 1.61a [1.22, 2.12] | 0.82 [0.61, 1.09] | 1.52a [1.10, 2.11] | 0.76a [0.56, 1.02] |
| Ref: Colorado | 1.00 | 1.00 | 1.00 | 1.00 |
| Age (in years) | -- | -- | 0.99 [0.97, 1.01] | 0.99 [0.97, 1.00] |
| Male | -- | -- | 0.79 [0.50, 1.25] | 0.74 [0.49, 1.12] |
| Ref: Female | -- | -- | 1.00 | 1.00 |
| Black | -- | -- | 0.88 [0.54, 1.44] | 0.79 [0.51, 1.23] |
| Asian | -- | -- | 4.89 [0.24, 99.21] | 1.12 [0.11, 10.93] |
| American Indian/Alaskan Native | -- | -- | 1.29 [0.56, 2.94] | 0.94 [0.44, 2.03] |
| Hawaiian/Pacific Islander | -- | -- | 0.75 [0.08, 7.40] | 0.76 [0.13, 4.37] |
| Multi-race | -- | -- | 0.97 [0.33, 2.88] | 1.17 [0.47, 2.91] |
| Missing | -- | -- | 1.17 [0.77, 1.79] | 0.91 [0.62, 1.32] |
| Ref: White | -- | -- | 1.00 | 1.00 |
| Hispanic/Latino | -- | -- | 0.83 [0.59, 1.19] | 0.86 [0.64, 1.17] |
| Missing | -- | -- | 0.87 [0.50, 1.54] | 0.93 [0.56, 1.55] |
| Ref: Not Hispanic/Latino | -- | -- | 1.00 | 1.00 |
| Married | -- | -- | 0.72 [0.46, 1.14] | 0.87 [0.58, 1.30] |
| Divorced | -- | -- | 0.70 [0.43, 1.13] | 0.84 [0.55, 1.28] |
| Separated | -- | -- | 0.51 [0.20, 1.26] | 0.56 [0.25, 1.24] |
| Widowed | -- | -- | 0.65 [0.33, 1.24] | 0.81 [0.45, 1.43] |
| Missing | -- | -- | 1.55 [0.37, 6.55] | 2.78 [0.81, 9.58] |
| Ref: Never Married | -- | -- | 1.00 | 1.00 |
| Insomnia indicationb | -- | -- | 17.39a [9.54, 31.69] | 1.02 [0.76, 1.36] |
| Ref: Did not have insomnia indication | -- | -- | 1.00 | 1.00 |
| Chronic prescription c (≥90 days) | -- | -- | 7.89a [5.15, 12.08] | 8.56a [5.93, 12.33] |
| Ref: Prescription <90 days | -- | -- | 1.00 | 1.00 |
| FDA approved for insomnia | -- | -- | 1.86a [1.44, 2.40] | 1.24 [0.97, 1.59] |
| Ref: Not FDA approved for insomnia | -- | -- | 1.00 | 1.00 |
a
p<0.05
b
# of participants with drug without FDA indication: model 3 (n=13), model 4 (n=169); # of participants with drug with FDA indication: model 3 (n= 632), model 4 (n=606)
c
# of participants without chronic prescription: model 3 (n= 26), model 4 (n=35) # of participants with chronic prescription: model 3 (n=619), model 4 (n=740)